Skip to content

Clinical trials

Atherosclerosis trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Not applicable Clear all

367 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20022
20032
20046
20055
20067
200711
200815
200916
201015
201120
20129
20139
201420
201517
201627
201717
201816
201918
202018
202119
202217
202322
202412
202518
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed204
Unknown status65
Recruiting43
Withdrawn16
Terminated13
Active, not recruiting12
Not yet recruiting11
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation9
Abbott Medical Devices7
Massachusetts General Hospital7
Xuanwu Hospital, Beijing7
Johns Hopkins University6
Maastricht University Medical Center6
Assistance Publique - Hôpitaux de Paris5
University of Texas at Austin5
Emory University4
Korea University Guro Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis367
Coronary Artery Disease73
Cardiovascular Diseases63
Peripheral Arterial Disease41
Inflammation26
Diabetes Mellitus20
Obesity17
Myocardial Infarction15
Myocardial Ischemia15
Diabetes Mellitus, Type 214

Trials

Showing 26 to 50 of 367. Each trial links to its page on Pharma Observatory.

267 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.